- AdventHealth
Orlando College of Osteopathic Medicine, AdventHealth University
create a formal pathway for pre-med students.
AdventHealth University and the soon-to-open Orlando College of Osteopathic Medicine announce a partnership that will keep more physicians in our community.
OCOM is being built at 7011 Kiran Patel Drive in Winter Garden, in the Horizon West neighborhood. The first class of 90 students is expected to matriculate in August 2024. AdventHealth University, established in 1992, offers dozens of healthcare degrees and certificates, including two pre-med tracks: a Bachelor’s degree in Health Sciences and a Bachelor’s degree in Biomedical Sciences.
Through this new relationship, AdventHealth University students and alumni in one of these two degree programs will be guaranteed interviews for admission into the Orlando College of Osteopathic Medicine. In addition, OCOM students will rotate through various specialties at AdventHealth hospitals, beginning in 2026. Several AdventHealth physicians also serve as OCOM faculty.
“We are thrilled to partner with the Orlando College of Osteopathic Medicine,” said C. Josef Ghosn, Ed.D, FACHE, president and CEO of AdventHealth University. “This partnership creates valuable pathways for our graduates to grow and succeed in the field of medicine.”
At full enrollment, OCOM plans to have 180 students, providing a viable workforce pipeline for the national and local physician labor shortage.
"OCOM is going to change healthcare for the region for generations to come," stated Dr. Robert Hasty, founding dean and chief academic officer of OCOM. "With an innovative medical school curriculum meticulously crafted by our esteemed faculty, our institution stands at the forefront of modern medical education. The educational journey that awaits our future medical students promises to be transformative. They will enter from esteemed schools like AdventHealth University and emerge as highly proficient and caring physicians, expected to fulfill the physician shortage within the Central Florida community.”
Students can apply to OCOM here. Learn more about AHU’s Bachelor of Science in Health Sciences and Bachelor of Science in Biomedical Sciences.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...